{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:47:42Z","timestamp":1791989262489,"version":"4.4.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":278,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021080","name":"Creutzfeldt-Jakob disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003107","name":"Federal Ministry of Health","doi-asserted-by":"publisher","award":["1369-341"],"award-info":[{"award-number":["1369-341"]}],"id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Digital enzyme-linked immunosorbent assays are based on single-molecule array technology. In this study, ubiquitin C-terminal hydrolase L1 (UCH-L1) levels were measured in cerebrospinal fluid (CSF) and blood samples (serum or plasma) obtained from patients with sporadic Creutzfeldt\u2013Jakob disease and fatal familial insomnia using a commercially available UCH-L1 assay. We determined the inter- and intra-assay variability as well as the stability of UCH-L1 detection to ensure a reliable assay performance. Cut-off values were calculated to differentiate prion disease patients from neurodegenerative and non-neurodegenerative control groups. Patients with Creutzfeldt\u2013Jakob disease exhibited significantly higher levels of UCH-L1 in both CSF and serum than controls. Receiver operating characteristic (ROC) analysis yielded area under the curve (AUC) values ranging from 0.91 to 0.97 for CSF and from 0.58 to 0.86 for serum. These values allow an excellent discrimination between Creutzfeldt\u2013Jakob disease patients and controls. Similar findings were observed in the fatal familial insomnia cohort. Here, ROC analysis indicated AUC values between 0.79 and 0.91 for CSF and up to 0.95 for plasma when distinguishing fatal familial insomnia patients from neurodegenerative, non-neurodegenerative and healthy controls. Altogether, our study suggests that detection of UCH-L1 levels in CSF and blood is suitable for the diagnosis of prion diseases.<\/jats:p>","DOI":"10.1093\/braincomms\/fcag363","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:00:42Z","timestamp":1790769642000},"source":"Crossref","is-referenced-by-count":0,"title":["Ubiquitin C-hydrolase L1 as a cerebrospinal fluid and blood biomarker for prion diseases"],"prefix":"10.1093","volume":"8","author":[{"given":"Sezgi","family":"Canaslan","sequence":"first","affiliation":[{"name":"Department of Neurology, University Medical Center G\u00f6ttingen and the German Center for Neurodegenerative Diseases (DZNE) , G\u00f6ttingen 37075 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5502-681X","authenticated-orcid":false,"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Medical Center G\u00f6ttingen and the German Center for Neurodegenerative Diseases (DZNE) , G\u00f6ttingen 37075 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lisa","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Medical Center G\u00f6ttingen and the German Center for Neurodegenerative Diseases (DZNE) , G\u00f6ttingen 37075 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Da Silva Correia","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Medical Center G\u00f6ttingen and the German Center for Neurodegenerative Diseases (DZNE) , G\u00f6ttingen 37075 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Da Silva Correia","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Medical Center G\u00f6ttingen and the German Center for Neurodegenerative Diseases (DZNE) , G\u00f6ttingen 37075 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyaba","family":"Saleem","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Medical Center G\u00f6ttingen and the German Center for Neurodegenerative Diseases (DZNE) , G\u00f6ttingen 37075 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hermann","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Medical Center G\u00f6ttingen and the German Center for Neurodegenerative Diseases (DZNE) , G\u00f6ttingen 37075 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Medical Center G\u00f6ttingen and the German Center for Neurodegenerative Diseases (DZNE) , G\u00f6ttingen 37075 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"23","key":"2026101410115713400_fcag363-B1","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"2026101410115713400_fcag363-B2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1212\/WNL.58.2.192","article-title":"Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease","volume":"58","author":"Otto","year":"2002","journal-title":"Neurology"},{"key":"2026101410115713400_fcag363-B3","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","article-title":"Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease","volume":"53","author":"Cramm","year":"2016","journal-title":"Mol Neurobiol"},{"key":"2026101410115713400_fcag363-B4","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/nprot.2016.120","article-title":"The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases","volume":"11","author":"Schmitz","year":"2016","journal-title":"Nat Protoc"},{"issue":"4","key":"2026101410115713400_fcag363-B5","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s12035-015-9167-5","article-title":"Validation of 14-3-3 protein as a marker in sporadic Creutzfeldt-Jakob disease diagnostic","volume":"53","author":"Schmitz","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"4","key":"2026101410115713400_fcag363-B6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","article-title":"CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease","volume":"67","author":"Sanchez-Juan","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"2026101410115713400_fcag363-B7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00401-017-1683-0","article-title":"Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: Diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A\u03b242 levels","volume":"133","author":"Lattanzio","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2026101410115713400_fcag363-B8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/brain\/awab350","article-title":"Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases","volume":"145","author":"Schmitz","year":"2022","journal-title":"Brain"},{"issue":"16","key":"2026101410115713400_fcag363-B9","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1042\/BCJ20160082","article-title":"Ubiquitin C-terminal hydrolase L1 (UCH-L1): Structure, distribution and roles in brain function and dysfunction","volume":"473","author":"Bishop","year":"2016","journal-title":"Biochem J"},{"issue":"3","key":"2026101410115713400_fcag363-B10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pneurobio.2009.10.020","article-title":"UCHL1 (PGP 9.5): Neuronal biomarker and ubiquitin system protein","volume":"90","author":"Day","year":"2010","journal-title":"Prog Neurobiol"},{"issue":"1981","key":"2026101410115713400_fcag363-B11","first-page":"1","article-title":"The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase","volume":"195","author":"Wilkinson","year":"1989","journal-title":"Science"},{"issue":"1","key":"2026101410115713400_fcag363-B12","first-page":"91","article-title":"The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies","volume":"69","author":"Wilson","year":"1988","journal-title":"Br J Exp Pathol"},{"issue":"2","key":"2026101410115713400_fcag363-B13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuint.2007.05.007","article-title":"The functions of UCH-L1 and its relation to neurodegenerative diseases","volume":"51","author":"Setsuie","year":"2007","journal-title":"Neurochem Int"},{"key":"2026101410115713400_fcag363-B14","doi-asserted-by":"crossref","first-page":"101856","DOI":"10.1016\/j.arr.2023.101856","article-title":"Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury","volume":"86","author":"Mi","year":"2023","journal-title":"Ageing Res Rev"},{"issue":"2","key":"2026101410115713400_fcag363-B15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/path.1711610210","article-title":"Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases","volume":"161","author":"Lowe","year":"1990","journal-title":"J Pathol"},{"issue":"1","key":"2026101410115713400_fcag363-B16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0092-8674(83)90207-6","article-title":"A protease-resistant protein is a structural component of the scrapie prion","volume":"35","author":"McKinley","year":"1983","journal-title":"Cell"},{"issue":"5","key":"2026101410115713400_fcag363-B17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4161\/pri.22309","article-title":"Prions, proteinase K and infectivity","volume":"6","author":"Sajnani","year":"2012","journal-title":"Prion"},{"issue":"5521","key":"2026101410115713400_fcag363-B18","first-page":"1552","article-title":"Impairment of the ubiquitin-proteasome system by protein aggregation","volume":"292","author":"Bence","year":"2001","journal-title":"Science (1979)."},{"key":"2026101410115713400_fcag363-B19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nbt.1641","article-title":"Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations","volume":"28","author":"Rissin","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"Pt 10","key":"2026101410115713400_fcag363-B20","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"issue":"3","key":"2026101410115713400_fcag363-B21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","article-title":"Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease","volume":"20","author":"Hermann","year":"2021","journal-title":"Lancet Neurol"},{"issue":"3","key":"2026101410115713400_fcag363-B22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s004399900124","article-title":"Molecular genetics of human prion diseases in Germany","volume":"105","author":"Windl","year":"1999","journal-title":"Hum Genet"},{"issue":"3","key":"2026101410115713400_fcag363-B23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"12","key":"2026101410115713400_fcag363-B24","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"2026101410115713400_fcag363-B25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12035-014-8709-6","article-title":"Characteristic CSF prion seeding efficiency in humans with prion diseases","volume":"51","author":"Cramm","year":"2015","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2026101410115713400_fcag363-B26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol"},{"key":"2026101410115713400_fcag363-B27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","article-title":"Sporadic and familial CJD: Classification and characterisation","volume":"66","author":"Gambetti","year":"2003","journal-title":"Br Med Bull"},{"issue":"4","key":"2026101410115713400_fcag363-B28","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.02952-14","article-title":"Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction","volume":"89","author":"Carroll","year":"2015","journal-title":"J Virol"},{"issue":"3","key":"2026101410115713400_fcag363-B29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(03)00323-5","article-title":"Familial and sporadic fatal insomnia","volume":"2","author":"Montagna","year":"2003","journal-title":"Lancet Neurol"},{"issue":"1","key":"2026101410115713400_fcag363-B30","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1038\/s41598-023-30237-3","article-title":"UCHL1, besides leptin and fibronectin, also could be a sensitive marker of the relapsing-remitting type of multiple sclerosis","volume":"13","author":"G\u00f3rska","year":"2023","journal-title":"Sci Rep"},{"key":"2026101410115713400_fcag363-B31","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s12035-017-0479-5","article-title":"Validation of \u03b1-synuclein as a CSF biomarker for sporadic Creutzfeldt-Jakob disease","volume":"55","author":"Llorens","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2026101410115713400_fcag363-B32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410430109","article-title":"Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease","volume":"43","author":"Zerr","year":"1998","journal-title":"Ann Neurol"},{"issue":"11","key":"2026101410115713400_fcag363-B33","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.neurobiolaging.2008.01.007","article-title":"14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes","volume":"30","author":"Gmitterov\u00e1","year":"2009","journal-title":"Neurobiol Aging"},{"key":"2026101410115713400_fcag363-B34","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199609263351303","article-title":"The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies","volume":"335","author":"Hsich","year":"1996","journal-title":"N Engl J Med"},{"issue":"9","key":"2026101410115713400_fcag363-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12035-022-02891-7","article-title":"Validation of plasma and CSF neurofilament light chain as an early marker for sporadic Creutzfeldt-Jakob disease","volume":"59","author":"Schmitz","year":"2022","journal-title":"Mol Neurobiol"},{"issue":"10","key":"2026101410115713400_fcag363-B36","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/acn3.51873","article-title":"High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob disease","volume":"10","author":"Abu-Rumeileh","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"issue":"8","key":"2026101410115713400_fcag363-B37","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/acn3.51141","article-title":"UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis","volume":"7","author":"Li","year":"2020","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcag363\/71627659\/fcag363.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/8\/5\/fcag363\/71627659\/fcag363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/8\/5\/fcag363\/71627659\/fcag363.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:12:08Z","timestamp":1791987128000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcag363\/8869029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcag363","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"fcag363"}}